Rosiglitazone decreases serum bone-specific alkaline phosphatase activity in postmenopausal diabetic women - Berberoglu, Z; Gursoy, A; Bayraktar, N; Yazici, A C; Tutuncu, N B; Demirag, N G (J Clin Endocrinol Metab, 2007)